Andréa Varga

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

Gilbert Habib, Paola Anna Erba, Bernard Iung et al. · European Heart Journal · 2019 · 867 citations · Full text

Medicine, Infectious Diseases, Radiology +15

Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer

Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman et al. · New England Journal of Medicine · 2015 · 664 citations · Full text

Medicine, Oncology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

Gilbert Habib, Patrizio Lancellotti, P.A. Erba et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2019 · 78 citations · Full text

Medicine, Cardiology, Infectious Diseases +13